CADL - Candel Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CADL is currently covered by 5 analysts with an average price target of $16.5. This is a potential upside of $8.31 (101.47%) from yesterday's end of day stock price of $8.19.

Candel Therapeutics's activity chart (see below) currently has 16 price targets and 28 ratings on display. The stock rating distribution of CADL is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 46.67 days.

Highest price target for CADL is $23, Lowest price target is $14, average price target is $16.5.

Most recent stock forecast was given by ALEC STRANAHAN from BAML on 21-Sep-2026. First documented stock forecast 23-Aug-2021.

Best performing analysts who are covering CADL - Candel Therapeutics:

Alec Stranahan Ilya Zubkov Sudan Loganathan Andres Maldonado

Currently out of the existing stock ratings of CADL, 9 are a BUY (75%), 3 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 18-May-2026

$18

$9.81 (119.78%)

$12

28 days ago
(21-Sep-2026)

3/5 (60%)

$6.79 (60.57%)

83

Buy Since 29-Sep-2025

$23

$14.81 (180.83%)

$23

2 months 6 days ago
(13-Aug-2026)

0/5 (0%)

$11.2 (94.92%)

Buy Since 20-Feb-2025

$22

7 months 1 days ago
(18-Mar-2026)

0/2 (0%)

$17.33 (371.09%)

Buy Since 19-Feb-2025

$25

7 months 6 days ago
(13-Mar-2026)

0/2 (0%)

$16.53 (195.16%)

Buy Since 28-Oct-2025

$15

$5.21 (53.22%)

$15

10 months 11 days ago
(08-Dec-2025)

0/2 (0%)

$9.55 (175.23%)

Show more analysts

Please expand the browser size to see the chart

What is CADL (Candel Therapeutics) average time for price targets to be met?

On average it took 47 days for the stock forecasts to be reached, with an average price target met ratio of 16.67%.

Which analyst most recently updated their price target on CADL (Candel Therapeutics)?

Alec Stranahan

Which analyst has the most public recommendations on CADL (Candel Therapeutics)?

Alec Stranahan works at BAML and has 7 price targets and 5 ratings on CADL

Which analyst is the currently most bullish on CADL (Candel Therapeutics)?

Chris Howerton with the highest potential upside of $17.17

Which analyst is the currently most reserved on CADL (Candel Therapeutics)?

Evan Seigerman with the lowest potential downside of -$5.19
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?